Publications

1. Singh M, El Sabbagh A, Lewis BR, Kanwar A, Terzic CM, Al-Hijji MA, Behfar A, Kirkland JL. Clinical Significance of Biological Age in Patients Undergoing Percutaneous Coronary Intervention. Mayo Clin Proc. 2023 Aug; 98(8):1137-1152.
   View PubMed
2. Terzic CM, Medina-Inojosa BJ. Cardiovascular Complications of Coronavirus Disease-2019. Phys Med Rehabil Clin N Am. 2023 Aug; 34 (3):551-561 Epub 2023 Mar 31
   View PubMed
3. Supervia M, Medina-Inojosa J, Martinez-Jarreta B, Lopez-Jimenez F, Vickers K, Terzic CM, Thomas RJ. Cardiac Rehabilitation Completion Study: Barriers and Potential Solutions. J Cardiopulm Rehabil Prev. 2022 Sep 1; 42 (5):375-377
   View PubMed
4. Whiteson JH, Azola A, Barry JT, Bartels MN, Blitshteyn S, Fleming TK, McCauley MD, Neal JD, Pillarisetti J, Sampsel S, Silver JK, Terzic CM, Tosto J, Verduzco-Gutierrez M, Putrino D. Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of cardiovascular complications in patients with post-acute sequelae of SARS-CoV-2 infection (PASC). PM R. 2022 Jul; 14 (7):855-878 Epub 2022 July 13
   View PubMed
5. Fine JS, Ambrose AF, Didehbani N, Fleming TK, Glashan L, Longo M, Merlino A, Ng R, Nora GJ, Rolin S, Silver JK, Terzic CM, Verduzco-Gutierrez M, Sampsel S. Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of cognitive symptoms in patients with post-acute sequelae of SARS-CoV-2 infection (PASC). PM R. 2022 Jan; 14 (1):96-111 Epub 2022 Jan 12
   View PubMed
6. Marwaha JS, Terzic CM, Kennedy DJ, Halamka J, Brat GA. Overwhelmed Hospitals May Soon Lead to Overwhelmed Rehabilitation Facilities Unless Post-Acute Care Infrastructure Is Strengthened. Am J Phys Med Rehabil. 2021 May 1; 100 (5):441-442
   View PubMed
7. Supervia M, Medina-Inojosa JR, Perez-Terzic CM, Sharma S, Goel K, Vickers Douglas K, Salz K, Thomas RJ. Impact of Musculoskeletal Limitations on Cardiac Rehabilitation Participation. Front Cardiovasc Med. 2021; 8:688483 Epub 2021 June 28
   View PubMed
8. Laskowski ER, Johnson SE, Shelerud RA, Lee JA, Rabatin AE, Driscoll SW, Moore BJ, Wainberg MC, Terzic CM. The Telemedicine Musculoskeletal Examination. Mayo Clin Proc. 2020 Aug; 95 (8):1715-1731
   View PubMed
9. Willett NJ, Boninger ML, Miller LJ, Alvarez L, Aoyama T, Bedoni M, Brix KA, Chisari C, Christ G, Dearth CL, Dyson-Hudson TA, Evans CH, Goldman SM, Gregory K, Gualerzi A, Hart J, Ito A, Kuroki H, Loghmani MT, Mack DL, Malanga GA, Noble-Haeusslein L, Pasquina P, Roche JA, Rose L, Stoddart MJ, Tajino J, Terzic C, Topp KS, Wagner WR, Warden SJ, Wolf SL, Xie H, Rando TA, Ambrosio F. Taking the Next Steps in Regenerative Rehabilitation: Establishment of a New Interdisciplinary Field. Arch Phys Med Rehabil. 2020 May; 101 (5):917-923 Epub 2020 Feb 05
   View PubMed
10. Diaz-Navarro R, Perez-Terzic C. Ethics of stem cell therapy for heart failure Rev Med Chile. 2019; 147:787-789.
    
11. Ghisi GLM, Santos CVA, Benaim B, Lopez-Jimenez F, Herdy AH, Inojosa JM, Terzic CM, Janovik L, Rojas MF, Grace SL. Severity of Depressive Symptoms Pre- and Postcardiac Rehabilitation: A COMPARISON AMONG PATIENTS IN BRAZIL, CANADA, COLOMBIA, THE UNITED STATES, AND VENEZUELA. J Cardiopulm Rehabil Prev. 2017 May; 37 (3):182-190
    View PubMed
12. Supervia M, Medina-Inojosa JR, Yeung C, Lopez-Jimenez F, Squires RW, Perez-Terzic CM, Brewer LC, Leth SE, Thomas RJ. Cardiac Rehabilitation for Women: A Systematic Review of Barriers and Solutions. Mayo Clin Proc. 2017 Mar 13 [Epub ahead of print]
    View PubMed
13. Faustino RS, Behfar A, Groenendyk J, Wyles SP, Niederlander N, Reyes S, Puceat M, Michalak M, Terzic A, Perez-Terzic C. Calreticulin secures calcium-dependent nuclear pore competency required for cardiogenesis. J Mol Cell Cardiol. 2016 Mar; 92:63-74 Epub 2016 Jan 27
    View PubMed
14. Subbotina E, Sierra A, Zhu Z, Gao Z, Koganti SR, Reyes S, Stepniak E, Walsh SA, Acevedo MR, Perez-Terzic CM, Hodgson-Zingman DM, Zingman LV. Musclin is an activity-stimulated myokine that enhances physical endurance. Proc Natl Acad Sci U S A. 2015 Dec 29; 112 (52):16042-7 Epub 2015 Dec 14
    View PubMed
15. Turk-Adawi KI, Terzic C, Bjarnason-Wehrens B, Grace SL. Cardiac rehabilitation in Canada and Arab countries: comparing availability and program characteristics. BMC Health Serv Res. 2015 Nov 26; 15:521
    View PubMed
16. Faustino RS, Wyles SP, Groenendyk J, Michalak M, Terzic A, Perez-Terzic C. Systems biology surveillance decrypts pathological transcriptome remodeling. BMC Syst Biol. 2015 Jul 17; 9:36 Epub 2015 July 17
    View PubMed
17. Wang Z, Perez-Terzic CM, Smith J, Mauck WD, Shelerud RA, Maus TP, Yang TH, Murad MH, Gou S, Terry MJ, Dauffenbach JP, Pingree MJ, Eldrige JS, Mohammed K, Benkhadra K, van Wijnen AJ, Qu W. Efficacy of intervertebral disc regeneration with stem cells - a systematic review and meta-analysis of animal controlled trials. Gene. 2015 Jun 10; 564 (1):1-8 Epub 2015 Mar 19
    View PubMed
18. Yamada S, Arrell DK, Martinez-Fernandez A, Behfar A, Kane GC, Perez-Terzic CM, Crespo-Diaz RJ, McDonald RJ, Wyles SP, Zlatkovic-Lindor J, Nelson TJ, Terzic A. Regenerative Therapy Prevents Heart Failure Progression in Dyssynchronous Nonischemic Narrow QRS Cardiomyopathy. J Am Heart Assoc. 2015 May 11; 4 (5)
    View PubMed
19. Crespo-Diaz R, Yamada S, Bartunek J, Perez-Terzic C, de Waele P, Mauen S, Terzic A, Behfar A. Cardiopoietic index predicts heart repair fitness of patient-derived stem cells. Biomark Med. 2015; 9 (7):639-49 Epub 2015 May 27
    View PubMed
20. Perez-Terzic C, Childers MK. Regenerative rehabilitation: a new future? Am J Phys Med Rehabil. 2014 Nov; 93 (11 Suppl 3):S73-8
    View PubMed
21. Behfar A, Terzic A, Perez-Terzic CM. Regenerative principles enrich cardiac rehabilitation practice. Am J Phys Med Rehabil. 2014 Nov; 93 (11 Suppl 3):S169-75
    View PubMed
22. Midence L, Mola A, Terzic CM, Thomas RJ, Grace SL. Ethnocultural diversity in cardiac rehabilitation. J Cardiopulm Rehabil Prev. 2014 Nov-Dec; 34 (6):437-44
    View PubMed
23. Gou S, Oxentenko SC, Eldrige JS, Xiao L, Pingree MJ, Wang Z, Perez-Terzic C, Qu W. Stem cell therapy for intervertebral disk regeneration. Am J Phys Med Rehabil. 2014 Nov; 93: (11 Suppl 3)S122-31.
    View PubMed
24. Alsara O, Reeves RK, Pyfferoen MD, Trenary TL, Engen DJ, Vitse ML, Kessler SM, Kushwaha SS, Clavell AL, Thomas RJ, Lopez-Jimenez F, Park SJ, Perez-Terzic CM. Inpatient rehabilitation outcomes for patients receiving left ventricular assist device. Am J Phys Med Rehabil. 2014 Oct; 93: (10)860-8.
    View PubMed
25. Martinez-Fernandez A, Nelson TJ, Reyes S, Alekseev AE, Secreto F, Perez-Terzic C, Beraldi R, Sung HK, Nagy A, Terzic A. iPS cell-derived cardiogenicity is hindered by sustained integration of reprogramming transgenes. Circ Cardiovasc Genet. 2014 Oct; 7 (5):667-76 Epub 2014 July 30
    View PubMed
26. Suresh R, Li X, Chiriac A, Goel K, Terzic A, Perez-Terzic C, Nelson TJ. Transcriptome from circulating cells suggests dysregulated pathways associated with long-term recurrent events following first-time myocardial infarction. J Mol Cell Cardiol. 2014 Sep; 74:13-21 Epub 2014 May 04
    View PubMed
27. Shanmugasegaram S, Perez-Terzic C, Jiang X, Grace SL. Cardiac rehabilitation services in low- and middle-income countries: a scoping review. J Cardiovasc Nurs. 2014 Sep-Oct; 29 (5):454-63
    View PubMed
28. Alsara O, Perez-Terzic C, Squires RW, Dandamudi S, Miranda WR, Park SJ, Thomas RJ. Is exercise training safe and beneficial in patients receiving left ventricular assist device therapy? J Cardiopulm Rehabil Prev. 2014 Jul-Aug; 34(4):233-40.
    View PubMed
29. Yamada S, Arrell DK, Kane GC, Nelson TJ, Perez-Terzic CM, Behfar A, Purushothaman S, Prinzen FW, Auricchio A, Terzic A. Mechanical dyssynchrony precedes QRS widening in ATP-sensitive K(+) channel-deficient dilated cardiomyopathy. J Am Heart Assoc. 2013 Dec 5; 2 (6):e000410 Epub 2013 Dec 05
    View PubMed
30. Suresh R, Chiriac A, Goel K, Villarraga HR, Lopez-Jimenez F, Thomas RJ, Terzic A, Nelson TJ, Perez-Terzic C. CXCR4+ and FLK-1+ identify circulating cells associated with improved cardiac function in patients following myocardial infarction. J Cardiovasc Transl Res. 2013 Oct; 6 (5):787-97 Epub 2013 Aug 10
    View PubMed
31. Yamada S, Nelson TJ, Kane GC, Martinez-Fernandez A, Crespo-Diaz RJ, Ikeda Y, Perez-Terzic C, Terzic A. Induced pluripotent stem cell intervention rescues ventricular wall motion disparity, achieving biological cardiac resynchronization post-infarction. J Physiol. 2013 Sep 1; 591 (17):4335-49 Epub 2013 Apr 08
    View PubMed
32. Faustino RS, Arrell DK, Folmes CD, Terzic A, Perez-Terzic C. Stem cell systems informatics for advanced clinical biodiagnostics: tracing molecular signatures from bench to bedside. Croat Med J. 2013 Aug; 54 (4):319-29
    View PubMed
33. Lopez-Jimenez F, Perez-Terzic C, Zeballos P, Anchique C, Burdiat G, Gonzalez K, Gonzalez G, Fernandez R, Santibanez C, Herdy A, Rodriguez Escudero J, Ilarraza-Lomeli H. Consenso rehabilitacion cardiovascular y prevencion secundaria de las sociedades interamericana y sudamericana de cardiologia. Rev Urug Cardiol. 2013 August; 28(2):189-224.
    
34. Folmes CD, Arrell DK, Zlatkovic-Lindor J, Martinez-Fernandez A, Perez-Terzic C, Nelson TJ, Terzic A. Metabolome and metaboproteome remodeling in nuclear reprogramming. Cell Cycle. 2013 Aug 1; 12 (15):2355-65 Epub 2013 July 08
    View PubMed
35. Folmes CD, Martinez-Fernandez A, Perales-Clemente E, Li X, McDonald A, Oglesbee D, Hrstka SC, Perez-Terzic C, Terzic A, Nelson TJ. Disease-causing mitochondrial heteroplasmy segregated within induced pluripotent stem cell clones derived from a patient with MELAS. Stem Cells. 2013 Jul; 31 (7):1298-308
    View PubMed
36. Folmes CD, Martinez-Fernandez A, Faustino RS, Yamada S, Perez-Terzic C, Nelson TJ, Terzic A. Nuclear reprogramming with c-Myc potentiates glycolytic capacity of derived induced pluripotent stem cells. J Cardiovasc Transl Res. 2013 Feb; 6 (1):10-21 Epub 2012 Dec 18
    View PubMed
37. Pack QR, Johnson LL, Barr LM, Daniels SR, Wolter AD, Squires RW, Perez-Terzic CM, Thomas RJ. Improving cardiac rehabilitation attendance and completion through quality improvement activities and a motivational program. J Cardiopulm Rehabil Prev. 2013 May-Jun; 33(3):153-9.
    View PubMed
38. Cortes-Bergoderi M, Lopez-Jimenez F, Herdy AH, Zeballos C, Anchique C, Santibanez C, Burdiat G, Gonzalez G, Gonzalez K, Finizola B, Fernandez R, Paniagua M, Thomas RJ, Gonzalez-Moreno J, Rodriguez-Escudero JP, Perez-Terzic C. Availability and characteristics of cardiovascular rehabilitation programs in South America. J Cardiopulm Rehabil Prev. 2013 Jan-Feb; 33 (1):33-41
    View PubMed
39. Perez-Terzic CM. Exercise in cardiovascular diseases. PM R. 2012 Nov; 4 (11):867-73
    View PubMed
40. Cortes-Bergoderi M, Thomas RJ, Albuquerque FN, Batsis JA, Burdiat G, Perez-Terzic C, Perez-Terzic C, Trejo-Gutierrez J, Lopez-Jimenez F. Validity of cardiovascular risk prediction models in Latin America and among Hispanics in the United States of America: a systematic review. Rev Panam Salud Publica. 2012 Aug; 32 (2):131-9
    View PubMed
41. Santibanez C, Perez-Terzic C, Lopez-Jimenez F, Cortes-Bergoderi M, Araya MV, Burdiat G. [Current status of cardiac rehabilitation in Chile]. Rev Med Chil. 2012 May; 140(5):561-8.
    View PubMed
42. Rodriguez-Escudero J, Perez-Terzic C, Allison T. The history of cardiac rehabilitation: a global vision. Avances Cardiol. 2012; 32(1):23-31.
    
43. Anchique CV, Perez-Terzic C, Lopez-Jimenez F, Cortes-Bergoderi M. Estado actual de la rehabilitacion cardiovascular en Colombia (2010). Revista Colombiana de Cardiologia. 2011 Nov-Dec; 18(6):305.
    
44. Folmes CD, Nelson TJ, Martinez-Fernandez A, Arrell DK, Lindor JZ, Dzeja PP, Ikeda Y, Perez-Terzic C, Terzic A. Somatic oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming. Cell Metab. 2011 Aug 3; 14 (2):264-71
    View PubMed
45. Burdiat G, Perez-Terzic C, Lopez-Jimenez F, Cortes-Bergoderi M, Santibanez C. Current situation of cardiac rehabilitation in Uruguay. Rev Urug Cardiol. 2011; 26:8-15.
    
46. Mola A, Perez-Terzic C, Thomas R, Rey M. Cardiovascular disparities: bridging cardiovascular health promotion. US Cardiology. 2011; 8(1):19-23.
    
47. Behfar A, Yamada S, Crespo-Diaz R, Nesbitt JJ, Rowe LA, Perez-Terzic C, Gaussin V, Homsy C, Bartunek J, Terzic A. Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction. J Am Coll Cardiol. 2010 Aug 24; 56 (9):721-34
    View PubMed
48. Terzic A, Perez-Terzic C. Channelopathies: decoding disease pathogenesis. Sci Transl Med. 2010 Jul 28; 2(42):42ps37.
    View PubMed
49. Goel K, Shen J, Wolter AD, Beck KM, Leth SE, Thomas RJ, Squires RW, Perez-Terzic CM. Prevalence of musculoskeletal and balance disorders in patients enrolled in phase II cardiac rehabilitation. J Cardiopulm Rehabil Prev. 2010 Jul-Aug; 30: (4)235-9.
    View PubMed
50. Faustino RS, Chiriac A, Niederlander NJ, Nelson TJ, Behfar A, Mishra PK, Macura S, Michalak M, Terzic A, Perez-Terzic C. Decoded calreticulin-deficient embryonic stem cell transcriptome resolves latent cardiophenotype. Stem Cells. 2010 Jul; 28 (7):1281-91
    View PubMed
51. Nelson TJ, Martinez-Fernandez A, Yamada S, Ikeda Y, Perez-Terzic C, Terzic A. Induced pluripotent stem cells: advances to applications. Stem Cells Cloning. 2010 Jan 1; 3:29-37
    View PubMed
52. Gersh BJ, Simari RD, Behfar A, Terzic CM, Terzic A. Cardiac cell repair therapy: a clinical perspective. Mayo Clin Proc. 2009 Oct; 84 (10):876-92
    View PubMed
53. Martinez-Fernandez A, Nelson TJ, Yamada S, Reyes S, Alekseev AE, Perez-Terzic C, Ikeda Y, Terzic A. iPS programmed without c-MYC yield proficient cardiogenesis for functional heart chimerism. Circ Res. 2009 Sep 25; 105 (7):648-56 Epub 2009 Aug 20
    View PubMed
54. Korenfeld Y, Mendoza-Bastidas C, Saavedra L, Montero-Gomez A, Perez-Terzic C, Thomas RJ, Sert-Kuniyoshi F, Vallejos J, Ibanez-Arenas R, Lopez-Jimenez F. Current status of cardiac rehabilitation in Latin America and the Caribbean. Am Heart J. 2009 Sep; 158 (3):480-7 Epub 2009 Aug 04
    View PubMed
55. Nelson TJ, Martinez-Fernandez A, Yamada S, Perez-Terzic C, Ikeda Y, Terzic A. Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation. 2009 Aug 4; 120 (5):408-16 Epub 2009 July 20
    View PubMed
56. Behfar A, Faustino RS, Arrell DK, Dzeja PP, Perez-Terzic C, Terzic A. Guided stem cell cardiopoiesis: discovery and translation. J Mol Cell Cardiol. 2008 Oct; 45 (4):523-9 Epub 2008 Sept 26
    View PubMed
57. Yamada S, Nelson TJ, Crespo-Diaz RJ, Perez-Terzic C, Liu XK, Miki T, Seino S, Behfar A, Terzic A. Embryonic stem cell therapy of heart failure in genetic cardiomyopathy. Stem Cells. 2008 Oct; 26(10):2644-53. Epub 2008 Jul 31.
    View PubMed
58. Baker DJ, Perez-Terzic C, Jin F, Pitel KS, Niederlander NJ, Jeganathan K, Yamada S, Reyes S, Rowe L, Hiddinga HJ, Eberhardt NL, Terzic A, van Deursen JM. Opposing roles for p16Ink4a and p19Arf in senescence and ageing caused by BubR1 insufficiency. Nat Cell Biol. 2008 Jul; 10 (7):825-36 Epub 2008 May 30
    View PubMed
59. Park S, Lim BB, Perez-Terzic C, Mer G, Terzic A. Interaction of asymmetric ABCC9-encoded nucleotide binding domains determines KATP channel SUR2A catalytic activity. J Proteome Res. 2008 Apr; 7 (4):1721-8 Epub 2008 Mar 01
    View PubMed
60. Faustino RS, Behfar A, Perez-Terzic C, Terzic A. Genomic chart guiding embryonic stem cell cardiopoiesis. Genome Biol. 2008 Jan 9; 9 (1):R6 Epub 2008 Jan 09
    View PubMed
61. Arrell DK, Niederlander NJ, Perez-Terzic C, Chung S, Behfar A, Terzic A. Pharmacoproteomics: advancing the efficacy and safety of regenerative therapeutics. Clin Pharmacol Ther. 2007 Sep; 82(3):316-9. Epub 2007 Aug 01.
    View PubMed
62. Faustino RS, Nelson TJ, Terzic A, Perez-Terzic C. Nuclear transport: target for therapy. Clin Pharmacol Ther. 2007 Jun; 81(6):880-6. Epub 2007 Apr 18.
    View PubMed
63. Behfar A, Perez-Terzic C, Faustino RS, Arrell DK, Hodgson DM, Yamada S, Puceat M, Niederlander N, Alekseev AE, Zingman LV, Terzic A. Cardiopoietic programming of embryonic stem cells for tumor-free heart repair. J Exp Med. 2007 Feb 19; 204 (2):405-20 Epub 2007 Feb 05
    View PubMed
64. Chung S, Dzeja PP, Faustino RS, Perez-Terzic C, Behfar A, Terzic A. Mitochondrial oxidative metabolism is required for the cardiac differentiation of stem cells. Nat Clin Pract Cardiovasc Med. 2007 Feb; 4 Suppl 1 (Suppl 1):S60-7
    View PubMed
65. Perez-Terzic C, Faustino RS, Boorsma BJ, Arrell DK, Niederlander NJ, Behfar A, Terzic A. Stem cells transform into a cardiac phenotype with remodeling of the nuclear transport machinery. Nat Clin Pract Cardiovasc Med. 2007 Feb; 4 Suppl 1:S68-76.
    View PubMed
66. Baker DJ, Jeganathan KB, Malureanu L, Perez-Terzic C, Terzic A, van Deursen JM. Early aging-associated phenotypes in Bub3/Rae1 haploinsufficient mice. J Cell Biol. 2006 Feb 13; 172 (4):529-40
    View PubMed
67. Behfar A, Hodgson DM, Zingman LV, Perez-Terzic C, Yamada S, Kane GC, Alekseev AE, Puceat M, Terzic A. Administration of allogenic stem cells dosed to secure cardiogenesis and sustained infarct repair. Ann N Y Acad Sci. 2005 May; 1049:189-98.
    View PubMed
68. Kane GC, Behfar A, Yamada S, Perez-Terzic C, O'Cochlain F, Reyes S, Dzeja PP, Miki T, Seino S, Terzic A. ATP-sensitive K+ channel knockout compromises the metabolic benefit of exercise training, resulting in cardiac deficits. Diabetes. 2004 Dec; 53 Suppl 3:S169-75
    View PubMed
69. O'Cochlain DF, Perez-Terzic C, Reyes S, Kane GC, Behfar A, Hodgson DM, Strommen JA, Liu XK, van den Broek W, Wansink DG, Wieringa B, Terzic A. Transgenic overexpression of human DMPK accumulates into hypertrophic cardiomyopathy, myotonic myopathy and hypotension traits of myotonic dystrophy. Hum Mol Genet. 2004 Oct 15; 13(20):2505-18. Epub 2004 Aug 18.
    View PubMed
70. Hodgson DM, Behfar A, Zingman LV, Kane GC, Perez-Terzic C, Alekseev AE, Puceat M, Terzic A. Stable benefit of embryonic stem cell therapy in myocardial infarction. Am J Physiol Heart Circ Physiol. 2004 Aug; 287 (2):H471-9
    View PubMed
71. Trushina E, Heldebrant MP, Perez-Terzic CM, Bortolon R, Kovtun IV, Badger JD 2nd, Terzic A, Estevez A, Windebank AJ, Dyer RB, Yao J, McMurray CT. Microtubule destabilization and nuclear entry are sequential steps leading to toxicity in Huntington's disease. Proc Natl Acad Sci U S A. 2003 Oct 14; 100 (21):12171-6 Epub 2003 Oct 03
    View PubMed
72. Hodgson DM, Zingman LV, Kane GC, Perez-Terzic C, Bienengraeber M, Ozcan C, Gumina RJ, Pucar D, O'Coclain F, Mann DL, Alekseev AE, Terzic A. Cellular remodeling in heart failure disrupts K(ATP) channel-dependent stress tolerance. EMBO J. 2003 Apr 15; 22 (8):1732-42
    View PubMed
73. Perez-Terzic C, Behfar A, Mery A, van Deursen JMA, Terzic A, Puceat M. Structural adaptation of the nuclear pore complex in stem cell-derived cardiomyocytes. Circ Res. 2003 Mar 7; 92(4):444-52.
    View PubMed
74. Mery A, Papadimou E, Zeineddine D, Menard C, Behfar A, Zingman LV, Hodgson DM, Rauzier JM, Kane GC, Perez-Terzic C, Terzic A, Puceat M. Commitment of embryonic stem cells toward a cardiac lineage: molecular mechanisms and evidence for a promising therapeutic approach for heart failure. J Muscle Res Cell Motil. 2003; 24(4-6):269-74.
    View PubMed
75. Zingman LV, Hodgson DM, Bast PH, Kane GC, Perez-Terzic C, Gumina RJ, Pucar D, Bienengraeber M, Dzeja PP, Miki T, Seino S, Alekseev AE, Terzic A. Kir6.2 is required for adaptation to stress. Proc Natl Acad Sci U S A. 2002 Oct 1; 99 (20):13278-83 Epub 2002 Sept 23
    View PubMed
76. Dzeja PP, Bortolon R, Perez-Terzic C, Holmuhamedov EL, Terzic A. Energetic communication between mitochondria and nucleus directed by catalyzed phosphotransfer. Proc Natl Acad Sci U S A. 2002 Jul 23; 99 (15):10156-61 Epub 2002 July 15
    View PubMed
77. Li J, Puceat M, Perez-Terzic C, Mery A, Nakamura K, Michalak M, Krause KH, Jaconi ME. Calreticulin reveals a critical Ca(2+) checkpoint in cardiac myofibrillogenesis. J Cell Biol. 2002 Jul 08; 158(1):103-13.
    View PubMed
78. Khurana VG, Perez-Terzic CM, Petersen RC, Krauss WE. Singing paraplegia: a distinctive manifestation of a spinal dural arteriovenous fistula. Neurology. 2002 Apr 23; 58 (8):1279-81
    View PubMed
79. Perez-Terzic C, Gacy AM, Bortolon R, Dzeja PP, Puceat M, Jaconi M, Prendergast FG, Terzic A. Directed inhibition of nuclear import in cellular hypertrophy. J Biol Chem. 2001 Jun 8; 276 (23):20566-71 Epub 2001 Mar 30
    View PubMed
80. Perez-Terzic C, Perez-Terzic C, Gacy AM, Bortolon R, Dzeja PP, Puceat M, Jaconi M, Prendergast FG, Terzic A. Structural plasticity of the cardiac nuclear pore complex in response to regulators of nuclear import. Circ Res. 1999 Jun 11; 84 (11):1292-301
    View PubMed
81. Perez-Terzic C, Jaconi M, Stehno-Bittel L. Measurement of intracellular calcium concentration using confocal microscopy. Methods Mol Biol. 1999; 114:75-91.
    View PubMed
82. Perez-Terzic C, Jaconi M, Clapham DE. Nuclear calcium and the regulation of the nuclear pore complex. Bioessays. 1997 Sep; 19(9):787-92.
    View PubMed
83. Perez-Terzic C, Stehno-Bittel L, Clapham DE. Nucleoplasmic and cytoplasmic differences in the fluorescence properties of the calcium indicator Fluo-3. Cell Calcium. 1997 Apr; 21 (4):275-82
    View PubMed
84. Perez-Terzic C, Pyle J, Perez-Terzic C, Jaconi M, Stehno-Bittel L, Clapham DE. Conformational states of the nuclear pore complex induced by depletion of nuclear Ca2+ stores. Science. 1996 Sep 27; 273 (5283):1875-7
    View PubMed
85. Perez-Terzic CM, Chini EN, Shen SS, Dousa TP, Clapham DE. Ca2+ release triggered by nicotinate adenine dinucleotide phosphate in intact sea urchin eggs. Biochem J. 1995 Dec 15; 312 ( Pt 3):955-9
    View PubMed
86. Stehno-Bittel L, Krapivinsky G, Krapivinsky L, Perez-Terzic C, Clapham DE, Perez-Terzic C. The G protein beta gamma subunit transduces the muscarinic receptor signal for Ca2+ release in Xenopus oocytes. J Biol Chem. 1995 Dec 15; 270 (50):30068-74
    View PubMed
87. Stehno-Bittel L, Perez-Terzic C, Clapham DE, Perez-Terzic C. Diffusion across the nuclear envelope inhibited by depletion of the nuclear Ca2+ store. Science. 1995 Dec 15; 270 (5243):1835-8
    View PubMed
88. Lopez JR, Perez C, Alfonzo M, Cordoves G, Linares N, Allen P. Changes in intracellular calcium concentration induced byinositol 1, 4, 5 triphosphate in human malignant hyperthermia skeletal muscle. Life Science Adv. 1994; 12:131-40.
    
89. Lopez JR, Perez C, Allen P. Abnormal calcium release induced by inositol 1, 4, 5 triphosphate in malignant hyperthermia skeletal muscle. Minerva Anestiologica. 1994; 60:141-4.
    
90. Lopez JR, Perez C, Alfonzo M, Linares N, Cordoves G, Allen P. Probable partecipazione dell'inosilolo 1, 4, 5 trisfosfato nella fisiopatologia dell'ipertermia maligna. Acta Anaesthesiologica Italica. 1993; 44:293-302.
    
91. Lopez JR, Perez C, Allen P, Alfonzo M, Linares N. Efecto del inositol 1, 4, 5 trisfosfato sobre la concentration de calcio en musculo esqueletico de sujetos susceptibles al sindrome de hipertermia maligna. Rev Arg Anes. 1992; 50:193-200.